Integrated “gut–liver”-on-a-chip (iGLoC): an immune-competent and metabolically active microphysiological model of the gut–liver axis for drug screening, validated by abemaciclib pharmacokinetics, hepatotoxicity, and drug–drug interaction studies
Lab on a Chip · 2026
DOI: 10.1039/d6lc00377j ↗Kurz gefasst
Fachartikel in der Zeitschrift Lab on a Chip, 2026. Verfasst von Sultan K AlShmmari und 4 weiteren Autor:innen. Beteiligte Einrichtung: Leibniz Institute of Photonic Technology, Member of Leibniz Health Technologies, Member of the Leibniz Centre for Photonics in Infection Research (LP…. Hauptthemen laut MEDLINE: Benzimidazoles, Liver, Aminopyridines, Lab-On-A-Chip Devices. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Alfaisal University.
Abstract (Originalsprache)
iGLoC: immune-competent in vitro model recapitulates gut–liver PK of abemaciclib, generating clinically relevant metabolites, DDIs, and hepatotoxicity signatures for preclinical screening of small-molecule cancer therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Leibniz Institute of Photonic Technology, Member of Leibniz Health Technologies, Member of the Leibniz Centre for Photonics in Infection Research (LPI), Albert-Einstein-Straße 9, 07745 Jena, Germany.
- College of Science & General Studies, Alfaisal University, Riyadh 11533, Saudi Arabia. qalramadan@alfaisal.edu.
- Institute of Physical Chemistry (IPC) and Abbe Center of Photonics (ACP), Friedrich Schiller University Jena, Member of the Leibniz Centre for Photonics in Infection Research (LPI), Helmholtzweg 4, 07743 Jena, Germany.
Förderung
- Alfaisal University
Zitieren
APA
AlShmmari, S. K., Cialla-May, D., Popp, J., Zourob, M., & Ramadan, Q. (2026). Integrated “gut–liver”-on-a-chip (iGLoC): an immune-competent and metabolically active microphysiological model of the gut–liver axis for drug screening, validated by abemaciclib pharmacokinetics, hepatotoxicity, and drug–drug interaction studies. Lab on a Chip. https://doi.org/10.1039/d6lc00377j
Vancouver
AlShmmari SK, Cialla-May D, Popp J, Zourob M, Ramadan Q. Integrated “gut–liver”-on-a-chip (iGLoC): an immune-competent and metabolically active microphysiological model of the gut–liver axis for drug screening, validated by abemaciclib pharmacokinetics, hepatotoxicity, and drug–drug interaction studies. Lab on a Chip. 2026. doi:10.1039/d6lc00377j
BibTeX
@article{AlShmmari2026,
author = {AlShmmari, Sultan K and Cialla-May, Dana and Popp, Jürgen and Zourob, Mohammed and Ramadan, Qasem},
title = {Integrated “gut–liver”-on-a-chip (iGLoC): an immune-competent and metabolically active microphysiological model of the gut–liver axis for drug screening, validated by abemaciclib pharmacokinetics, hepatotoxicity, and drug–drug interaction studies},
journal = {Lab on a Chip},
year = {2026},
doi = {10.1039/d6lc00377j}
}
EUVIMED